Additional Information
Book Details
Abstract
Continuous ambulatory peritoneal dialysis (CAPD) was introduced by Popovich et al. in 1976, with 4–6 exchanges per day and long dwell time between the exchanges. Later, a group from Seattle used the combination of cyclic and automated PD in their patients and then it was called as continuous automated ambulatory peritoneal dialysis (CAAPD). Later in 1981, this technique was given the name continuous cycling peritoneal dialysis (CCPD) by Diaz-Buxo. Currently, over 130,000 patients are on CAPD worldwide, and it is the most popular form of peritoneal dialysis.
This book on continuous ambulatory peritoneal dialysis is designed to address the various clinical decision questions supported by typical clinical scenarios, with which all readers will be able to identify. Thus, it provides an excellent opportunity to widen one’s perspective in this area.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover\r | Front Cover | ||
| Front Matter \r | ia | ||
| Copyright | id | ||
| ECAB Clinical Update:Nephrology \r | ie | ||
| Continuous Ambulatory Peritoneal Dialysis | if | ||
| About The Authors\r | ig | ||
| Contents | ii | ||
| ECAB Clinical Update informatin Continuous Ambulatory Peritoneal Dialysis \r | i | ||
| Physiology of PeritonealDialysis and Urea Kinetics | 1a | ||
| ABSTRACT | 1a | ||
| KEYWORDS | 1a | ||
| PERITONEAL MEMBRANE | 1 | ||
| Anatomy | 1 | ||
| Mesothelium | 2 | ||
| Basement Membrane | 2 | ||
| Interstitium | 2 | ||
| Blood Vessels | 3 | ||
| Peritoneal Lymphatics | 3 | ||
| ANATOMIC FINDINGS IN PD PATIENTS | 3 | ||
| PERITONEUM AS A DIALYSIS SYSTEM | 4 | ||
| Models of Peritoneal Transport | 4 | ||
| Physiology of Peritoneal Transport | 6 | ||
| Solute Transport by Diffusion | 6 | ||
| Ultrafiltra | 7 | ||
| Solute Transport by Convection | 8 | ||
| Lymphatic Absorption | 8 | ||
| Electrolytes Transport | 9 | ||
| Kine | 10 | ||
| CLINICAL OBSERVATIONS OFPERITONEAL MEMBRANE FUNCTION | 12 | ||
| Characterization of Peritoneal Membrane Transport | 12 | ||
| Stability of Peritoneal Membrane Over Time | 13 | ||
| UREA KINETICS AND ADEQUACY OF PD | 15 | ||
| CALCULATION OF SOLUTE CLEARANCE | 15 | ||
| Weekly Kt/Vurea | 16 | ||
| Adjustment for Body Size | 16 | ||
| Residual Renal Function | 17 | ||
| Peritoneal Creatinine Clearance | 17 | ||
| Targets for Adequate Dialysis | 18 | ||
| Peritoneal Membrane Transport | 19 | ||
| Peak BUN as Determinant of Well-Being | 20 | ||
| FLUID BALANCE | 20 | ||
| Assessment | 21 | ||
| PATIENT COMPLIANCE | 21 | ||
| Clinical Use ofPeritoneal Dialysis | 24a | ||
| ABSTRACT | 24a | ||
| KEYWORDS | 24b | ||
| PRINCIPLES OF PERITONEAL DIALYSIS2,3 | 25 | ||
| PRESENT STATUS OF PD WORLDWIDE5–7 | 25 | ||
| Peritoneal Dialysis and Renal Failure | 27 | ||
| Indications for PD as a Renal Replacement Therapy | 27 | ||
| Renal Indications of PD | 27 | ||
| Extra Renal Indications for PD | 28 | ||
| Survival Advantages on PD | 30 | ||
| PERITONEAL DIALYSIS AS BRIDGE TOKIDNEY TRANSPLANTATION | 30 | ||
| PERITONEAL DIALYSIS IN FEMALES | 31 | ||
| PERITONEAL DIALYSIS IN CHILDRENWITH ESRD | 31 | ||
| PERITONEAL DIALYSIS AND THE HEART | 33 | ||
| PERITONEAL DIALYSIS INHEPATIC FAILURE45–51 | 34 | ||
| PD IN ACUTE PANCREATITIS52–54 | 35 | ||
| HYPOTHERMIA AND HYPERTHERMIA55–58 | 35 | ||
| DIALYSIS-ASSOCIATED ASCITES59 | 36 | ||
| POISONINGS60 | 36 | ||
| QUALITY OF LIFE (QOL) IN PD | 36 | ||
| DIET ALTERATIONS OF PD PATIENTS66 | 37 | ||
| COSTS | 38 | ||
| PATIENT SELECTION OFTREATMENT MODALITY | 39 | ||
| Center Effect of Treatment | 39 | ||
| Patient Preference | 40 | ||
| Medical Factors Affecting Initial Choice of Modality | 41 | ||
| CONCLUSION | 41 | ||
| Infectious Complicationsof ContinuousPeritoneal Dialysis | 47a | ||
| ABSTRACT | 47a | ||
| KEYWORDS | 47b | ||
| EXIT-SITE AND TUNNEL INFECTIONS | 48 | ||
| Management | 50 | ||
| Grading Systems | 51 | ||
| Ultrasonography | 51 | ||
| Initial Antibiotic Therapy | 52 | ||
| Mild | 52 | ||
| Moderate Infec | 52 | ||
| Fungal Infec | 58 | ||
| Resistant Infection | 58 | ||
| Indications for Catheter Removal | 59 | ||
| Site and Timing of New Catheter Placement | 60 | ||
| Prevention/Treatment of Recurrent Infection | 60 | ||
| Mupirocin | 60 | ||
| Rifampicin | 60 | ||
| PATHOPHYSIOLOGY AND PREVENTIONOF PERITONITIS IN CONTINUOUSPERITONEAL DIALYSIS | 61 | ||
| Pathophysiology | 61 | ||
| Recommendations | 66 | ||
| Management of Peritonitis | 66 | ||
| Treatment and Recommendations | 75 | ||
| SUMMARY | 86 | ||
| Noninfectious Complicationsof Peritoneal Dialysis | 90a | ||
| ABSTRACT | 90a | ||
| KEYWORDS | 90a | ||
| CATHETER MALFUNCTION | 90 | ||
| METABOLIC COMPLICATIONS | 92 | ||
| HERNIAE | 92 | ||
| Risk Factors | 93 | ||
| Diagnosis | 93 | ||
| Prevention and Treatment | 93 | ||
| HYDROTHORAX | 93 | ||
| Diagnosis | 94 | ||
| Peritoneal Dialysis inAcute Care Setting | 101a | ||
| ABSTRACT | 101a | ||
| KEYWORDS | 101a | ||
| INTRODUCTION | 101 | ||
| PERITONEAL DIALYSIS—ANUNDERUTILIZED RRT MODALITY | 101 | ||
| IS PD EFFECTIVE IN THE CRITICALLY ILL | 104 | ||
| TECHNIQUES OF PERITONEAL DIALYSIS | 105 | ||
| Acute Intermitted Peritoneal Dialysis | 105 | ||
| Chronic Equilibrated Peritoneal Dialysis (CEPD) | 105 | ||
| Tidal Peritoneal Dialysis | 105 | ||
| High Volume Peritoneal Dialysis | 106 | ||
| Continuous Flow Peritoneal Dialysis | 106 | ||
| PERITONEAL ACCESS DEVICES | 106 | ||
| Acute Catheters | 106 | ||
| Chronic Catheters | 107 | ||
| ACUTE PD PRESCRIPTION | 107 | ||
| RELATIVE CONTRAINDICATIONS TOACUTE PD | 109 | ||
| COMPLICATIONS OF ACUTE PD | 109 | ||
| Infectious Complications | 109 | ||
| Mechanical Complications | 109 | ||
| Medical Complications | 110 | ||
| PD IN SPECIAL SETTINGS | 111 | ||
| Acute PD in Critical Ill Children | 111 | ||
| PD Access in Neonates/Infants and Small Children | 112 | ||
| Non-renal Indications for Acute PD | 113 | ||
| Peritoneal Dialysis in Congestive Heart Failure | 113 | ||
| Other Non-renal Indications | 114 | ||
| CONCLUSIONS | 115 | ||
| Other Books in This Series | 119 |